Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Kelly Services Kelya Stock Suitable For Dividend Investors Price At 8.65 Down 0.69 20260328 Is Ceragon Crnt Stock Breaking Support Price At 2.23 Up 1.83 20260406 Will Elicio Therapeutics Eltx Stock Hit Record Highs Price At 9.90 Down 1.88 20260408 Is Uranium Energy Uec Stock Entering Maturity Stage Uec Q4 Earnings Beats Estimates By 0.01 20260409 1 Why IP IPST could be the anchor your portfolio needs Flirts with Breakout 20260511 Media Sector Operational Reputational Risk HighProfile Talent Exit Amid Ethical Internal Probe IMKTA Ingles reports 54 yearoveryear Q1 2026 revenue drop shares slip 062 in todays trading RKDA Arcadia Biosciences delivers huge Q3 2025 EPS beat even as revenue falls slightly year over year CDXS Codexis Q1 loss narrows EPS beats by 28 percent yet shares slide 386 percent despite results The Federal Reserves Independence Hanging by a Thread in the Trump Era NYT Bestseller Lists A Market Force and the Persistent Attempts to Influence Them RBI Raises Bond Trading Target for Primary Dealers by 48 to 4 Lakh Crore Marc Jacobs Label Changes Hands LVMH Divests After Three Decades Designer Retains Creative Role US Tariff Policy May Moderate Trade Representative Hints at Lower but Persistent Barriers US Consumer Prices Rise 38 Annually in April Surpassing Forecasts JEPQs High Distribution Yield Unpacking the ELN Counterparty Risk Japans Megabanks Achieve Record Profits but Analysts Caution as Credit and Geopolitical Risks Loom UK Police Chiefs Propose Blocking Unsafe Social Media for Under16s Raising Regulatory Risks for Tech Firms Portugals Meo Sues State for 82 Million Over Huawei 5G Exclusion AWI Q1 2026 Earnings EPS Falls Short of Estimates Amid Market Challenges ARW Q1 2026 Earnings Massive EPS Beat of 81 but Stock Slides Slightly GLUE Q1 2026 Earnings WiderThanExpected Loss as PreClinical Biotech Advances Pipeline AREB Q1 2026 Earnings Deep Losses Reported Stock Surges Over 22 ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline